CN Patent

CN117580583A — Pcsk9抑制剂和glp-1受体激动剂的药物组合

Assigned to Gan and Lee Pharmaceuticals Co Ltd · Expires 2024-02-20 · 2y expired

What this patent protects

本发明涉及一种药物组合，所述药物组合包含PCSK9抑制剂和GLP‑1受体激动剂；还涉及所述药物组合在制备用于治疗高血糖症、糖尿病，肥胖和/或胆固醇相关疾病的药物中的用途。

USPTO Abstract

本发明涉及一种药物组合，所述药物组合包含PCSK9抑制剂和GLP‑1受体激动剂；还涉及所述药物组合在制备用于治疗高血糖症、糖尿病，肥胖和/或胆固醇相关疾病的药物中的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN117580583A
Jurisdiction
CN
Classification
—
Expires
2024-02-20
Drug substance claim
No
Drug product claim
No
Assignee
Gan and Lee Pharmaceuticals Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.